|
1
|
Wreczycka-Cegielny P, Cegielny T, Oplawski
M, Sawicki W and Kojs ZC: Current treatment options for advanced
choriocar-cinoma on the basis of own case and review of the
literature. Ginekol Pol. 89:711–715. 2018. View Article : Google Scholar
|
|
2
|
Cheung AN, Zhang HJ, Xue WC and Siu MK:
Pathogenesis of choriocarcinoma: Clinical, genetic and stem cell
perspectives. Future Oncol. 5:217–231. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wells M: The pathology of gestational
trophoblastic disease: Recent advances. Pathology. 39:88–96. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Becherer JD and Blobel CP: Biochemical
properties and functions of membrane-anchored
metallprotease-disintegrin proteins (ADAMs). Curr Top Dev Biol.
54:101–123. 2003. View Article : Google Scholar
|
|
5
|
Klein T and Bischoff R: Active
metalloproteases of the A disin-tegrin and metalloprotease (ADAM)
family: Biological function and structure. J Proteome Res.
10:17–33. 2011. View Article : Google Scholar
|
|
6
|
Roy R, Wewer UM, Zurakowski D, Pories SE
and Moses MA: ADAM 12 cleaves extracellular matrix proteins and
correlates with cancer status and stage. J Biol Chem.
279:51323–51330. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fröhlich C, Nehammer C, Albrechtsen R,
Kronqvist P, Kveiborg M, Sehara-Fujisawa A, Mercurio AM and Wewer
UM: ADAM12 produced by tumor cells rather than stromal cells
accelerates breast tumor progression. Mol Cancer Res. 9:1449–1461.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Roy R, Rodig S, Bielenberg D, Zurakowski D
and Moses MA: ADAM12 transmembrane and secreted isoforms promote
breast tumor growth: A distinct role for ADAM12-S protein in tumor
metastasis. J Biol Chem. 286:20758–20768. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kveiborg M, Fröhlich C, Albrechtsen R,
Tischler V, Dietrich N, Holck P, Kronqvist P, Rank F, Mercurio AM
and Wewer UM: A role for ADAM12 in breast tumor progression and
stromal cell apoptosis. Cancer Res. 65:4754–4761. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li H, Duhachek-Muggy S, Dubnicka S and
Zolkiewska A: Metalloproteinase-disintegrin ADAM12 is associated
with a breast tumor-initiating cell phenotype. Breast Cancer Res
Treat. 139:691–703. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rao VH, Vogel K, Yanagida JK, Marwaha N,
Kandel A, Trempus C, Repertinger SK and Hansen LA: Erbb2
up-regulation of ADAM12 expression accelerates skin cancer
progression. Mol Carcinog. 54:1026–1036. 2015. View Article : Google Scholar
|
|
12
|
Cheon DJ, Li AJ, Beach JA, Walts AE, Tran
H, Lester J, Karlan BY and Orsulic S: ADAM12 is a prognostic factor
associated with an aggressive molecular subtype of high-grade
serous ovarian carcinoma. Carcinogenesis. 36:739–747. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Carl-McGrath S, Lendeckel U, Ebert M,
Roessner A and Röcken C: The disintegrin-metalloproteinases ADAM9,
ADAM12, and ADAM15 are upregulated in gastric cancer. Int J Oncol.
26:17–24. 2005.
|
|
14
|
Mino N, Miyahara R, Nakayama E, Takahashi
T, Takahashi A, Iwakiri S, Sonobe M, Okubo K, Hirata T, Sehara A
and Date H: A disintegrin and metalloprotease 12 (ADAM12) is a
prognostic factor in resected pathological stage I lung
adenocarcinoma. J Surg Oncol. 100:267–272. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peduto L, Reuter VE, Sehara-Fujisawa A,
Shaffer DR, Scher HI and Blobel CP: ADAM12 is highly expressed in
carcinoma-associated stroma and is required for mouse prostate
tumor progression. Oncogene. 25:5462–5466. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kodama T, Ikeda E, Okada A, Ohtsuka T,
Shimoda M, Shiomi T, Yoshida K, Nakada M, Ohuchi E and Okada Y:
ADAM12 is selectively overexpressed in human glioblastomas and is
associated with glioblastoma cell proliferation and shedding of
heparin-binding epidermal growth factor. Am J Pathol.
165:1743–1753. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rao VH, Kandel A, Lynch D, Pena Z, Marwaha
N, Deng C, Watson P and Hansen LA: A positive feedback loop between
HER2 and ADAM12 in human head and neck cancer cells increases
migration and invasion. Oncogene. 31:2888–2898. 2012. View Article : Google Scholar :
|
|
18
|
Georges S, Chesneau J, Hervouet S,
Taurelle J, Gouin F, Redini F, Padrines M, Heymann D, Fortun Y and
Verrecchia F: A disintegrin and metalloproteinase 12 produced by
tumour cells accelerates osteosarcoma tumour progression and
associated osteolysis. Eur J Cancer. 49:2253–2263. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roy R and Moses MA: ADAM12 induces
estrogen-independence in breast cancer cells. Breast Cancer Res
Treat. 131:731–741. 2012. View Article : Google Scholar
|
|
20
|
Klionsky DJ: Autophagy revisited: A
conversation with Christian de Duve. Autophagy. 4:740–743. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kobayashi S: Choose delicately and reuse
adequately: The newly revealed process of autophagy. Biol Pharm
Bull. 38:1098–1103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Thorburn A: Apoptosis and autophagy:
Regulatory connections between two supposedly different processes.
Apoptosis. 13:1–9. 2008. View Article : Google Scholar :
|
|
26
|
Doherty J and Baehrecke EH: Life, death
and autophagy. Nat Cell Biol. 20:1110–1117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan Z and Zhang Y, Deng J, Zeng G and
Zhang Y: Purified vitexin compound 1 suppresses tumor growth and
induces cell apoptosis in a mouse model of human choriocarcinoma.
Int J Gynecol Cancer. 22:360–366. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deng J, Zhang Y and Tan Z: Proliferation
and apoptosis of choriocarcinoma cell JEG-3 induced by VB2 and its
in vitro mechanism. Zhong Nan Da Xue Xue Bao Yi Xue Ban.
38:476–782. 2013.In Chinese. PubMed/NCBI
|
|
29
|
Peng Z, Zhang C, Zhou W, Wu C and Zhang Y:
The STAT3/NFIL3 signaling axis-mediated chemotherapy resistance is
reversed by Raddeanin A via inducing apoptosis in choriocarcinoma
cells. J Cell Physiol. 233:5370–5382. 2018. View Article : Google Scholar :
|
|
30
|
Wu C, Yu S, Tan Q, Guo P and Liu H: Role
of AhR in regulating cancer stem cell-like characteristics in
choriocarcinoma. Cell Cycle. 17:2309–2320. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shi D and Zhang Y, Lu R and Zhang Y: The
long non-coding RNA MALAT1 interacted with miR-218 modulates
choriocarcinoma growth by targeting Fbxw8. Biomed Pharmacother.
97:543–550. 2018. View Article : Google Scholar
|
|
32
|
Cheng CJ, Bahal R, Babar IA, Pincus Z,
Barrera F, Liu C, Svoronos A, Braddock DT, Glazer PM, Engelman DM,
et al: MicroRNA silencing for cancer therapy targeted to the tumour
microenvironment. Nature. 518:107–110. 2015. View Article : Google Scholar
|
|
33
|
Denton D, Nicolson S and Kumar S: Cell
death by autophagy: Facts and apparent artefacts. Cell Death
Differ. 19:87–95. 2012. View Article : Google Scholar :
|
|
34
|
Anding AL and Baehrecke EH: Autophagy in
cell life and cell death. Curr Top Dev Biol. 114:67–91. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arakawa S, Tsujioka M, Yoshida T,
Tajima-Sakurai H, Nishida Y, Matsuoka Y, Yoshino I, Tsujimoto Y and
Shimizu S: Role of Atg5-dependent cell death in the embryonic
development of Bax/Bak double-knockout mice. Cell Death Differ.
24:1598–1608. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shimizu S, Kanaseki T, Mizushima N, Mizuta
T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2
family proteins in a non-apoptotic programmed cell death dependent
on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lamy L, Ngo VN, Emre NC, Shaffer AL III,
Yang Y, Tian E, Nair V, Kruhlak MJ, Zingone A, Landgren O and
Staudt LM: Control of autophagic cell death by caspase-10 in
multiple myeloma. Cancer Cell. 23:435–449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu L, Alva A, Su H, Dutt P, Freundt E,
Welsh S, Baehrecke EH and Lenardo MJ: Regulation of an ATG7-beclin
1 program of autophagic cell death by caspase-8. Science.
304:1500–1502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Elgendy M, Sheridan C, Brumatti G and
Martin SJ: Oncogenic Ras-induced expression of Noxa and Beclin-1
promotes autophagic cell death and limits clonogenic survival. Mol
Cell. 42:23–35. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Byun JY, Yoon CH, An S, Park IC, Kang CM,
Kim MJ and Lee SJ: The Rac1/MKK7/JNK pathway signals upregulation
of Atg5 and subsequent autophagic cell death in response to
onco-genic Ras. Carcinogenesis. 30:1880–1888. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Dasari SK, Bialik S, Levin-Zaidman S,
Levin-Salomon V, Merrill AH Jr, Futerman AH and Kimchi A:
Signalome-wide RNAi screen identifies GBA1 as a positive mediator
of autoph-agic cell death. Cell Death Differ. 24:1288–1302. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Debnath J, Baehrecke EH and Kroemer G:
Does autophagy contribute to cell death? Autophagy. 1:66–74. 2005.
View Article : Google Scholar
|
|
43
|
Dalby KN, Tekedereli I, Lopez-Berestein G
and Ozpolat B: Targeting the prodeath and prosurvival functions of
autophagy as novel therapeutic strategies in cancer. Autophagy.
6:322–329. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Susin SA, Lorenzo HK, Zamzami N, Marzo I,
Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler
M, et al: Molecular characterization of mitochondrial
apoptosis-inducing factor. Nature. 397:441–446. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen W, Li N, Chen T, Han Y, Li C, Wang Y,
He W, Zhang L, Wan T and Cao X: The lysosome-associated
apoptosis-inducing protein containing the pleckstrin homology (PH)
and FYVE domains (LAPF), representative of a novel family of PH and
FYVE domain-containing proteins, induces caspase-independent
apoptosis via the lysosomal-mitochondrial pathway. J Biol Chem.
280:40985–40995. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen D, Zheng X, Kang D, Yan B, Liu X, Gao
Y and Zhang K: Apoptosis and expression of the Bcl-2 family of
proteins and P53 in human pancreatic ductal adenocarcinoma. Med
Princ Pract. 21:68–73. 2012. View Article : Google Scholar
|
|
47
|
Gursan N, Karakök M, Sari I and Gursan MS:
The relationship between expression of p53/Bcl-2 and
histopathological criteria in breast invasive ductal carcinomas.
Int J Clin Pract. 55:589–590. 2001.
|
|
48
|
Hemann MT and Lowe SW: The p53-Bcl-2
connection. Cell Death Differ. 13:1256–1259. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Wesselborg S and Stork B: Autophagy signal
transduction by ATG proteins: From hierarchies to networks. Cell
Mol Life Sci. 72:4721–4757. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI,
Woo HN, Cho DH, Choi B, Lee H, Kim JH, et al: Essential roles of
Atg5 and FADD in autophagic cell death: Dissection of autophagic
cell death into vacuole formation and cell death. J Bio Chem.
280:20722–20729. 2005. View Article : Google Scholar
|
|
51
|
Mehrpour M, Esclatine A, Beau I and
Codogno P: Overview of macroautophagy regulation in mammalian
cells. Cell Res. 20:748–762. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Otomo C, Metlagel Z, Takaesu G and Otomo
T: Structure of the human ATG12~ATG5 conjugate required for LC3
lipidation in autophagy. Nat Struct Mol Biol. 20:59–66. 2013.
View Article : Google Scholar :
|
|
53
|
Cadwell K, Stappenbeck TS and Virgin HW:
Role of autophagy and autophagy genes in inflammatory bowel
disease. Curr Top Microbiol Immunol. 335:141–167. 2009.PubMed/NCBI
|
|
54
|
Fésüs L, Demény MÁ and Petrovski G:
Autophagy shapes inflammation. Antioxid Redox Signal. 14:2233–2243.
2011. View Article : Google Scholar
|
|
55
|
Levine B, Mizushima N and Virgin HW:
Autophagy in immunity and inflammation. Nature. 469:323–335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Chen YM, Chang CY, Chen HH, Hsieh CW, Tang
KT, Yang MC, Lan JL and Chen DY: Association between autophagy and
inflammation in patients with rheumatoid arthritis receiving
biologic therapy. Arthritis Res Ther. 20:2682018. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Saitoh T and Akira S: Regulation of innate
immune responses by autophagy-related proteins. J Cell Biol.
189:925–935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Deretic V: Multiple regulatory and
effector roles of autophagy in immunity. Curr Opin Immunol.
21:53–62. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Harris J: Autophagy and cytokines.
Cytokine. 56:140–144. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Harris J and Keane J: How tumour necrosis
factor blockers interfere with tuberculosis immunity. Clin Exp
Immunol. 161:1–9. 2010.PubMed/NCBI
|
|
61
|
Yang R, Zhang Y, Wang L, Hu J, Wen J, Xue
L, Tang M, Liu Z and Fu J: Increased autophagy in fibroblast-like
synoviocytes leads to immune enhancement potential in rheumatoid
arthritis. Oncotarget. 8:15420–15430. 2017.PubMed/NCBI
|
|
62
|
Harris J, Lang T, Thomas JPW, Sukkar MB,
Nabar NR and Kehrl JH: Autophagy and inflammasomes. Mol Immunol.
86:10–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Shi CS, Shenderov K, Huang NN, Kabat J,
Abu-Asab M, Fitzgerald KA, Sher A and Kehrl JH: Activation of
autophagy by inflammatory signals limits IL-1β production by
targeting ubiquitinated inflammasomes for destruction. Nat Immunol.
13:255–263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Morselli E, Galluzzi L, Kepp O, Vicencio
JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor
functions of autophagy. Biochim Biophys Acta. 1793:1524–1532. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wu H and Lozano G: NF-kappa B activation
of p53. A potential mechanism for suppressing cell growth in
response to stress. J Biol Chem. 269:20067–20074. 1994.PubMed/NCBI
|
|
66
|
Catz SD and Johnson JL: Transcriptional
regulation of bcl-2 by nuclear factor kappa B and its significance
in prostate cancer. Oncogene. 20:7342–7351. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Grimm S, Bauer MK, Baeuerle PA and
Schulze-Osthoff K: Bcl-2 down-regulates the activity of
transcription factor NF-kappaB induced upon apoptosis. J Cell Biol.
134:13–23. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Boakye YD, Groyer L and Heiss EH: An
increased autophagic flux contributes to the antiinflammatory
potential of urolithin A in macrophages. Biochim Biophys Acta Gen
Subj. 1862:61–70. 2018. View Article : Google Scholar
|
|
69
|
Liu T, Zhang L, Joo D and Sun SC: NF-κB
signaling in inflammation. Signal Transduct Target Ther. 2:pii:
17023. 2017. View Article : Google Scholar
|
|
70
|
Davignon JL, Hayder M, Baron M, Boyer JF,
Constantin A, Apparailly F, Poupot R and Cantagrel A: Targeting
mono-cytes/macrophages in the treatment of rheumatoid arthritis.
Rheumatology (Oxford). 52:590–598. 2013. View Article : Google Scholar
|
|
71
|
Ip WKE, Hoshi N, Shouval DS, Snapper S and
Medzhitov R: Anti-inflammatory effect of IL-10 mediated by
metabolic reprogramming of macrophages. Science. 356:513–519. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Ko JH, Yoon SO, Lee HJ and Oh JY:
Rapamycin regulates macrophage activation by inhibiting NLRP3
inflammasome-p38 MAPK-NFκB pathways in autophagy- and p62-dependent
manners. Oncotarget. 8:40817–40831. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Inoki K and Guan KL: Complexity of the TOR
signaling network. Trends Cell Biol. 16:206–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Reiling JH and Sabatini DM: Stress and
mTORture signaling. Oncogene. 25:6373–6383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Sarbassov DD, Ali SM and Sabatini DM:
Growing roles for the mTOR pathway. Curr Opin Cell Biol.
17:596–603. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Wu YT, Tan HL, Shui G, Bauvy C, Huang Q,
Wenk MR, Ong CN, Codogno P and Shen HM: Dual role of
3-methylad-enine in modulation of autophagy via different temporal
patterns of inhibition on class I and III phosphoinositide
3-kinase. J Biol Chem. 285:10850–10861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Jung CH, Ro SH, Cao J, Otto NM and Kim DH:
mTOR regulation of autophagy. FEBS Lett. 584:1287–1295. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Kim YC and Guan KL: mTOR: A pharmacologic
target for autophagy regulation. J Clin Invest. 125:25–32. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Paquette M, EI-Houjeiri L and Pause A:
mTOR pathways in cancer and autophagy. Cancers (Basel). 10:pii:
E18. 2018. View Article : Google Scholar
|
|
80
|
Dunlop EA and Tee AR: mTOR and autophagy:
A dynamic relationship governed by nutrients and energy. Semin Cell
Dev Biol. 36:121–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Nah J, Yuan J and Jung YK: Autophagy in
neurodegenerative diseases: From mechanism to therapeutic approach.
Mol Cells. 38:381–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Guo F, Liu X, Cai H and Le W: Autophagy in
neurodegenerative diseases: Pathogenesis and therapy. Brain Pathol.
28:3–13. 2018. View Article : Google Scholar
|
